AAVAnc80-antiVEGF gene therapy

· Akouos, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAVAnc80-antiVEGF gene therapy, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy